DEVICES & DIGITAL

Digital therapeutics (e.g., EndeavorRx)

Regulated software treatments—different from general wellness apps.

How it works

Prescription digital therapeutics are apps or games that have gone through FDA review for a specific use. EndeavorRx is a video game designed to train attention.

What the evidence says, use by use

Evidence is specific to the condition, population and—for devices—the exact product. One label never covers everything.

ADHD: Improving attention on computer-based tests

Emerging / limited
Who was studied / who it’s for: Children 8–12 with inattentive or combined ADHDRegulatory status: FDA De Novo (2020), prescription only.What this label means: Early, small or mixed studies. Interesting, but not equivalent to established care.

FDA authorized EndeavorRx in 2020 based on improved scores on a computerized attention test; it was not shown to improve broader ADHD symptoms on its own and is meant as part of a treatment program.

Sources: FDA (2020)

Who usually provides it

Prescribing clinicians; check the exact product’s clearance and indication.

Cautions & things to know

  • Most mental-health apps are not regulated treatments—look for evidence on the specific product.

Questions for a clinician

Conversation prompts, not a treatment plan.

  • What exactly is this product cleared to do?
  • How will we measure whether it’s helping in daily life?

Educational, not medical advice. NeuroCoach is an educational and care-navigation resource, not a medical provider. Information about medications, supplements, therapies, devices, clinical trials and community experiences is provided for education and exploration and is not a recommendation, diagnosis or treatment plan. Evidence varies substantially among interventions. Decisions about medical or mental-health treatment should be made with an appropriately qualified healthcare professional. Do not start, stop or change medication, supplements or treatment based solely on information found here.

Sources

Sources checked October 5, 2026. Links support this page; they don’t imply endorsement of NeuroCoach.

  1. De Novo decision summary: EndeavorRx FDA (2020)